Brief: TG Therapeutics Q3 Net Income USD 113.93 Mln
01/11/2023 11:38
Nov 1 (Reuters) - TG Therapeutics Q3 net income USD 113.93 million. * Q3 product revenue USD 25.068 million * Q3 operating income USD 114.784 million
Recent news on TG Therapeutics
See all newsTG Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tg Therapeutics Reports Second Quarter 2026 Financial Results And Raises Briumvi® Revenue Guidance
TG Therapeutics Q2 product revenue rises 70% on BRIUMVI sales
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj